Pages that link to "Q48847179"
Jump to navigation
Jump to search
The following pages link to Complement activation by neurofibrillary tangles in Alzheimer's disease (Q48847179):
Displaying 50 items.
- Using animal models to determine the significance of complement activation in Alzheimer's disease (Q24796236) (← links)
- Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways (Q26830542) (← links)
- Microglia communication: Parallels between aging and Alzheimer's disease (Q28074099) (← links)
- Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues (Q30492292) (← links)
- Can oral infection be a risk factor for Alzheimer's disease? (Q33361553) (← links)
- The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration (Q33685823) (← links)
- Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease (Q33793485) (← links)
- Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses (Q34042437) (← links)
- Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice (Q34076162) (← links)
- Alzheimer's disease risk genes and mechanisms of disease pathogenesis (Q34425904) (← links)
- Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis (Q34471200) (← links)
- Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease (Q34550347) (← links)
- Inflammation in neurodegenerative disease--a double-edged sword (Q34775762) (← links)
- Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease (Q35114490) (← links)
- Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma (Q35191570) (← links)
- Yin and Yang: complement activation and regulation in Alzheimer’s disease (Q35563953) (← links)
- Complement receptors and the shaping of the natural antibody repertoire (Q35991469) (← links)
- Evidence that immunoglobulin-positive neurons in Alzheimer's disease are dying via the classical antibody-dependent complement pathway (Q36186740) (← links)
- Microglial malfunction: the third rail in the development of Alzheimer's disease (Q36348184) (← links)
- Do glia drive synaptic and cognitive impairment in disease? (Q36539354) (← links)
- Systemic and acquired immune responses in Alzheimer's disease (Q36902286) (← links)
- What does complement do in Alzheimer's disease? Old molecules with new insights (Q37368120) (← links)
- Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting (Q37387826) (← links)
- Expression of complement system components during aging and amyloid deposition in APP transgenic mice (Q37443394) (← links)
- Protective effects of decay-accelerating factor on blast-induced neurotrauma in rats (Q37485157) (← links)
- CCAAT-enhancer binding protein-β expression and elevation in Alzheimer's disease and microglial cell cultures (Q37505868) (← links)
- The role of the complement system and the activation fragment C5a in the central nervous system (Q37599686) (← links)
- RIG-1 receptor expression in the pathology of Alzheimer's disease (Q37688406) (← links)
- Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord (Q37702966) (← links)
- Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing (Q37718997) (← links)
- The role of the complement system in CNS inflammatory diseases (Q37754532) (← links)
- Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature (Q37982377) (← links)
- Fibrinogen and altered hemostasis in Alzheimer's disease (Q38032520) (← links)
- Alzheimer's disease genetics: from the bench to the clinic (Q38225911) (← links)
- Inflammation in Alzheimer's Disease and Molecular Genetics: Recent Update (Q38558744) (← links)
- Viral-derived complement inhibitors: current status and potential role in immunomodulation (Q38995165) (← links)
- Neuroinflammation in Neurodegenerative Disorders-a Review (Q39173756) (← links)
- Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease (Q39217121) (← links)
- Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects (Q39222559) (← links)
- Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma. (Q39904367) (← links)
- Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease. (Q40390704) (← links)
- Effects of Aged Garlic Extract on Cholinergic, Glutamatergic and GABAergic Systems with Regard to Cognitive Impairment in Aβ-Induced Rats (Q41195032) (← links)
- The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets (Q41439008) (← links)
- Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease (Q42044152) (← links)
- Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. (Q42292861) (← links)
- Microglia, Alzheimer's disease, and complement (Q42322507) (← links)
- Plaque complement activation and cognitive loss in Alzheimer's disease (Q43111970) (← links)
- The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. (Q44374035) (← links)
- Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization (Q44833066) (← links)
- Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN. (Q47751388) (← links)